Scope of the
Report
The report titled “Global Biosimilar Market: Trends & Opportunities (2015 Edition)” analyzes the global biologics market, with exhaustive discussion on demand of Biosimilars with increase in patent expiry of innovator drugs. The key market challenges recognized by the analysts and the major trends biosimilar market are presented in the report. Further, key manufacturers of Biosimilars like Sandoz, Teva, Hospira and Dr. Reddy’s Lab are profiled in the report.
The report titled “Global Biosimilar Market: Trends & Opportunities (2015 Edition)” analyzes the global biologics market, with exhaustive discussion on demand of Biosimilars with increase in patent expiry of innovator drugs. The key market challenges recognized by the analysts and the major trends biosimilar market are presented in the report. Further, key manufacturers of Biosimilars like Sandoz, Teva, Hospira and Dr. Reddy’s Lab are profiled in the report.
Purchase a copy of Global
Biosimilar Market visit @ http://www.orbisresearch.com/contact/purchase/185270 For more information contact sales@orbisresearch.com .
Product Coverage
Recombinant Glycosylated Biosimilars (EPO,mAb,Follitropin)
Humira, Enbrel, Remicade, Herceptin
Recombinant Non-Glycosylated Biosimilars (Insulin,G-csf,Interferons,hGh)
Recombinant Glycosylated Biosimilars (EPO,mAb,Follitropin)
Humira, Enbrel, Remicade, Herceptin
Recombinant Non-Glycosylated Biosimilars (Insulin,G-csf,Interferons,hGh)
Company Coverage
Sandoz(Novartis)
Hospira
Teva
Dr. Reddy’s Lab
Sandoz(Novartis)
Hospira
Teva
Dr. Reddy’s Lab
Executive Summary
Rising budgetary pressures to reduce healthcare expenditures, patent expiries of blockbuster drugs, growing demand for cost-effective alternatives, increasing aging population, conductive government initiatives and rising incidences of various diseases are significant factors that are responsible for the growth of global biosimilar market (2013 to 2018). On the other hand stringent regulatory environment in some countries, high manufacturing complexities, costs, and presence of low priced generic drugs and high-entry barriers are considered to hinder the market growth. Emerging pharmaceutical market and less stringent government regulatory frameworks in few countries can provides some of the major opportunities for biosimilars market. In addition, increased collaboration between manufacturing companies and outsourcing of biosimilar products are key trends for biosimilars market.
Rising budgetary pressures to reduce healthcare expenditures, patent expiries of blockbuster drugs, growing demand for cost-effective alternatives, increasing aging population, conductive government initiatives and rising incidences of various diseases are significant factors that are responsible for the growth of global biosimilar market (2013 to 2018). On the other hand stringent regulatory environment in some countries, high manufacturing complexities, costs, and presence of low priced generic drugs and high-entry barriers are considered to hinder the market growth. Emerging pharmaceutical market and less stringent government regulatory frameworks in few countries can provides some of the major opportunities for biosimilars market. In addition, increased collaboration between manufacturing companies and outsourcing of biosimilar products are key trends for biosimilars market.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/185270 .
The biosimilar
products market is segmented into recombinant non-glycosylated proteins,
recombinant glycosylated proteins, and recombinant peptides. Globally there are
280 biosimilars in pipeline and their clinical trials are increasing at a rate
of 20% annually.
The report titled
“The Global Biosimilar Market: Trends & Opportunities (2014-2018)” provides
an in-depth analysis of the growing Biosimilar Market with detailed analysis of
market sizing and growth, market share and economic impact of the industry. The
report also assesses the key opportunities in the market and outlines the
factors that are and will be driving the growth of the industry. Growth of the
overall Biosimilars industry has also been forecasted for the period 2014-18,
taking into consideration the previous growth patterns, the growth drivers and
the current and future trends. Further, key players of the industry like
Sandoz, Teva, Hospira and Dr. Reddy’s Lab are profiled.
Browse Complete Report @ http://www.orbisresearch.com/reports/index/global-biosimilar-market-trends-and-opportunities-2015-edition .
Some points from TOC:
1. Executive Summary
2. Global Biosimilar Market
2.1 Overview of Biosimilar Market
2.1.1 History
2.1.2 Prescription of Biosimilars
2.1.3 Naming of Biosimilars
2.1.4 Determination of Biosimilarity
2.1.5 Differences between Biosimilar and Original Drugs
2.1.6 Manufacture of Biosimilars
2.1.7 Safety, Efficacy, Quality
2.1.8 Variability in Biosimilars
2.1.9Regulating Biosimilars
2.1.10 Approval Pathways of Biosimilars
2.1.11Market Segmentation by Therapeutic Area
2.1 Overview of Biosimilar Market
2.1.1 History
2.1.2 Prescription of Biosimilars
2.1.3 Naming of Biosimilars
2.1.4 Determination of Biosimilarity
2.1.5 Differences between Biosimilar and Original Drugs
2.1.6 Manufacture of Biosimilars
2.1.7 Safety, Efficacy, Quality
2.1.8 Variability in Biosimilars
2.1.9Regulating Biosimilars
2.1.10 Approval Pathways of Biosimilars
2.1.11Market Segmentation by Therapeutic Area
3. Global Biosimilar Market: Sizing
and Growth
3.1 Biosimilar Market Size: 2009-2013
3.2 Forecasted Biosimilar market Size : 2014-2018
3.1 Biosimilar Market Size: 2009-2013
3.2 Forecasted Biosimilar market Size : 2014-2018
About Us:
Orbis Research (orbisresearch.com) is a
single point aid for all your market research requirements. We have vast
database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our
clients. We have complete information about our publishers and hence are sure
about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required
market research study for our clients.
Contact
Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1
(214) 884-6817; +9164101019
No comments:
Post a Comment